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Abstract
In order to study the short-time effects of two bioactive low-molecular amelogenins A+4 and A-4,
half-moon cavities were prepared in the mesial aspect of the first maxillary molars, and after pulp
exposure, agarose beads alone (controls) or beads soaked in A+4 or A-4 (experimental) were
implanted into the pulp. After 1, 3 or 7 days, the rats were killed and the teeth studied by
immunohistochemistry. Cell proliferation was studied by PCNA labeling, positive at 3 days, but
decreasing at day 7 for A+4, whilst constantly high between 3 and 7 days for A-4. The differentiation
toward the osteo/odontoblast lineage shown by RP59 labeling was more apparent for A-4
compared with A+4. Osteopontin-positive cells were alike at days 3 and 7 for A-4. In contrast, for
A+4, the weak labeling detected at day 3 became stronger at day 7. Dentin sialoprotein (DSP), an
in vivo odontoblast marker, was not detectable until day 7 where a few cells became DSP positive
after A-4 stimulation, but not for A+4. These results suggest that A +/- 4 promote the proliferation
of some pulp cells. Some of them further differentiate into osteoblast-like progenitors, the effects
being more precocious for A-4 (day 3) compared with A+4 (day 7). The present data suggest that
A +/- 4 promote early recruitment of osteogenic progenitors, and evidence functional differences
between A+4 and A-4.
Introduction
For more than 75 years dental surgeons have used calcium
hydroxide for pulp capping [15] after an accidental pulp
exposure during the removal of carious dentin or the
preparation of a cavity. The sequence of events leading to
reparative dentin formation is well documented, but
some cellular and molecular mechanisms still need to be
clarified. As a result of the high alkaline pH of Ca(OH)2 a
scar is formed at the surface of the exposed pulp. Eventu-
ally, some pulp cells are committed, proliferate and differ-
entiate into odontoblast-like or osteoblast-like cells
producing an extracellular matrix (ECM). This structure
can mineralize and form a reparative dentinal bridge [31]
but the dentinal bridge may be inhomogeneous and dis-
play fissures where pulp remnants are located, forming a
defective barrier, unable to prevent the pulp from bacte-
rial contamination. Nevertheless, for decades this was the
only biological approach aiming to heal and keep the
pulp alive.
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[21,22] and [29,30] were pioneers in exploring the thera-
peutic effects of bioactive molecules, namely Bone Mor-
phogenetic Proteins (BMPs). BMPs are implicated in the
early development of the tooth [14], and are also present
in the mature dentin [9]. In addition, BMPs and their
receptors have been identified in the dental pulp [35,36].
Pulp capping with BMPs stimulate the formation of repar-
ative osteodentin. Since that time, other dentin ECM mol-
ecules were also shown to enhance reparative dentin
formation (see for reviews: [12,13]).
In dentin and pulp, collagens constitute the major com-
ponents, however collagen fibrils function more as poten-
tial carriers rather than bioactive molecules. Therefore an
increasing interest has been directed toward a series of
dentin collagen-interactive non-collagenous proteins
(NCP). NCP molecules include firstly phosphorylated
proteins, among which the SIBLING family appears to
play major roles, especially as mineralization modulators
[10]. Dentin sialoprotein (DSP), dentin glycoprotein
(DGP), and dentin phosphoprotein (DPP) result from the
cleavage of the native dentin sialophosphoprotein
(DSPP). DSPP is expressed in a contiguous region on the
long arm of chromosome 4q 21.3 5 together with dentin
matrix protein-1, osteopontin (OPN), bone sialoprotein
(BSP), and MEPE. Amelogenins and decorin are also
phosphorylated, but to a lesser extent. Phospholipids
associated with proteins as proteolipids, have also been
identified as dentin ECM molecules.
Secondly, non-phosphorylated proteins [osteocalcin,
osteonectin, small leucine-rich CS/DS and KS proteogly-
cans, serum-derived glycoproteins, enzymes such as alka-
line or acid phosphatases, metalloproteases, disintegrins,
and a limited number of growth factors (TGFβ, ILGF-1
and -2, FGFs)] belong to the family of NCP dentin pro-
teins.
Phosphorylated and non-phosphorylated ECM compo-
nents may function as structural proteins, as matricellular
molecules with the capacity to link to the cell cytoskele-
ton, or as biological mediators of cell functions. In the
later capacity they may 1) function as signaling molecules,
2) regulate growth factor, cytokine or hormone produc-
tion, and 3) control the availability or activity of proteins
sequestered within the ECM, binding or releasing growth
factors (GF) and hormones [3,1]. As multifunctional pro-
teins, ECM molecules have the capacity to be involved
simultaneously in each of the three facets. Altogether, they
are prominently involved in the formation, structure and
mineralization of dentin and bone. In addition, some of
them may promote pulp healing.
We have previously investigated the bioactivity of two
amelogenin gene splice products A+4 and A-4, which
induce either the formation of a dentinal bridge closing
the pulp exposure (A+4), or promoting the massive for-
mation of reparative dentin, both in the crown and root
pulp (A-4) [33,19]. To summarize what is actually known
firstly, a low molecular weight (6 – 10 kDa) polypeptide
isolated from the rat incisor dentin matrix was found to
have the capacity to stimulate in vitro embryonic muscle
fibroblasts to express sulfated proteoglycans and type II
collagen. For this reason the molecule was designated
originally as being a Chondrogenic Inducing Agent (CIA)
[2]. Secondly, the CIA was identified as a low molecular
mass amelogenin polypeptide [23]. Thirdly, Veis and his
collaborators [40] identified in the rat incisor tooth odon-
toblast/pulp library two specific cDNAs, the first resulting
from expression of amelogenin gene exons 2, 3, 4, 5, 6 d,
and 7 [A+4, 8.1 kDa] and the second from exons 2, 3, 5, 6
d and 7, the expression of exon 4 being omitted [A-4, 6.9
kDa]. Added to the culture medium, A+4 stimulated Sox9
expression whereas A-4 stimulated Cbfa1 mRNA expres-
sion. In the mouse enamel organ, the larger full length
(M194) and near full length (M180) amelogenin iso-
forms are the principal products directing the formation
of the mineralized enamel. The M194 mRNA includes
both the full exon 6 and exon 4 sequences, while M180,
the major mature amelogenin mRNA, still excludes exon
4. The corresponding short forms, M73 (A+4) and M59
(A-4, LRAP) include, or exclude the 14 amino acid
sequence encoded by exon 4.
M194, M180 and M59 proteins are all produced, at differ-
ent levels, within the mouse enamel organ, with M73
being present at much smaller levels. However, M73 and
M59 are expressed by odontoblasts at the perinatal devel-
opment period [37,16]. It has been postulated that the
odontoblast produced M73 and M59 are secreted into the
ECM, and during the period before dentin mineralization
blocks ameloblast-odontoblast communication, they are
taken up by the cells, where they perform their signaling
function. Internalization of M59 (A-4) appears to be
mediated by the cell transmembrane receptor LAMP-1,
originally identified as a lysosomal membrane protein, in
ameloblasts, odontoblasts and stratum intermedium cells
[38,32]. Altogether, in vitro and in vivo experiments sug-
gest that these amelogenin gene splice products are sign-
aling molecules [39,19]. It was on this basis that the M59
and M73 were studied for their potential in dentin repair.
In in vivo implantation studies carried out for periods of 8
d, 15 d, 30 d and 90 d we observed the formation of repar-
ative dentin or diffuse mineralization 2 weeks after
implantation of A +/- 4 in the exposed pulp of rat maxil-
lary molars [33]. In parallel, to get a better understanding
of the mechanisms involved, the in vitro effects of A+4 and
A-4 on clones of odontoblast progenitors were analyzed
[26]. When A+4 or A-4 were added to the culture medium,Head & Face Medicine 2007, 3:40 http://www.head-face-med.com/content/3/1/40
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RT-PCR analysis showed that it takes 48 h to stimulate the
expression of DSP and osteocalcin [19]. From in vitro and
in vivo studies it may be concluded that in the cascade of
events leading to cell commitment, proliferation of pro-
genitors is initiated between 24 to 48 h after exposure to
A +/- 4, while the terminal differentiation occurs about 7
days after implantation. Consequently, we decide to
investigate in vivo the short-term effects of A +/- 4 implan-
tation.
Materials and methods
100 μg of A+4 or A-4 were dissolved in a 150 ml solution
of PBS. Affi-gel agarose microbeads (70–150 μm in diam-
eter, Biorad, Hercules, CA) were incubated in the A+4/PBS
or A-4/PBS solution for 1 hour at 37°C. Each bead
absorbed approximately 0.2 μg of A+4 or A-4.
Operative procedure
The preparation of the animals and pulp exposure was
carried out as previously reported [33]. In brief, after gin-
gival electrosurgery, half-moon-shaped Class V cavities
were prepared on the mesial aspect of the first maxillary
molars. Pulp perforation was accomplished by pressure
with the tip of a steel probe. Soaked (A +/- 4 groups) and
unsoaked (control group) agarose beads were implanted
into the pulp, and the cavity was filled with a glass iono-
mer cement (Fuji II, GC Corporation, Tokyo, Japan) to
prevent bacterial contamination.
Bead implantation
Ninety maxillary first molars from 45 Sprague-Dawley
rats, aged 8 weeks, were used (~350 g). The experiment
was carried out according to regulations for animal care
and approved by the Scientific Committee of the Dental
Faculty.
The two experimental groups of 36 teeth (group A-4) and
32 teeth (group A+4) were implanted with small molecu-
lar weight amelogenin-soaked agarose beads. Four to six
beads were implanted per pulp. Both groups were distrib-
uted into three subgroups to be evaluated at 1, 3 and 7
days respectively.
The control group included 22 teeth implanted with aga-
rose beads alone. This group included 4 teeth at day 1, 12
teeth at day 3 and 6 teeth at day 7. We have previously
reported the effects of sham preparations, calcium
hydroxide and implantation of other bioactive molecules,
using these same methods, the same strain of rats and
therefore these experiments were not repeated [7].
Specimen preparation for light microscopy evaluation
After 1, 3 and 7 days, respectively, the rats were killed by
cardiac perfusion with a fixative solution containing 4%
paraformaldehyde buffered with 0.1 M sodium
cacodylate at pH 7.2–7.4. Block sections including the
three molars were dissected from the maxilla, immersed
in the fixative solution for 24 h at 4°C, and demineralized
with 4.13% EDTA pH 7.2–7.4, renewed each 3 days for 8
weeks. The dehydrated tissues were embedded in Para-
plast (Oxford Labware, St Louis, MO, USA). Five μm thick
serial sections were cut, dewaxed and stained with hema-
toxylin-eosin or Masson's trichrome to evaluate tissue
responses.
Immunohistochemical evaluation
Proliferation was evaluated by immunodetection of the
proliferating cell nuclear antigen (PCNA) [6,28], using a
mouse monoclonal PCNA antibody (PC-10, Dako, Gol-
strup, Denmark) at 1/75e dilution in PBS-1% BSA.
Adjacent sections were labeled with the following primary
antibodies: rabbit anti-RP59, a marker for osteoblast pro-
genitors implicated in osteoblast recruitment [41] (kindly
provided by Dr T. Wurtz, Paris 7) at 1/500 dilution, with
anti-osteopontin (OPN) (LF 153) and anti-dentin sialo-
protein (DSP) (LF153) at 1/100 dilution (kindly provided
by Dr L Fisher, NIDCR-NIH, Bethesda, Maryland, USA).
The sections were further incubated with the secondary
antibody with 1/100 dilution of peroxidase-conjugated
goat anti-mouse IgG for the PCNA visualization or with a
peroxidase-conjugated swine anti-rabbit IgG at 1/100
concentration for RP59, OPN and DSP (Dako, Golstrup,
Denmark). The antibody localization was visualized with
a solution of 3–3' diamino-benzidine (DAB, Sigma, St
Louis, MO, USA) and H2O2 for 20 minutes. Controls were
carried out by omitting the primary antisera from the
labeling procedure, and using the secondary antibody
alone. Previous immunoblot studies have assessed the
presence of the molecules in the tissue and the specificity
of the antibodies.
Results
Markers
The experiments were designed to discriminate between
the in vivo effects due to the surgery and implantation of
the untreated beads and the cascade of events resulting
from the implantation of beads containing the amelo-
genin gene splice products into the pulp. Four markers
were used to characterize the events occurring during the
first 7 days after pulp implantation. The first marker was
aimed at assessing the stimulation of cell proliferation.
The antibody raised against the proliferative cell nuclear
antigen (PCNA) was selected because it provides a reliable
immunocytochemical method for visualizing the dividing
cells within a tissue [6,28]. The other three markers, RP59,
OPN and DSP, are less reliable in the sense that they may
be less specific. Thus, it is the combinations of these mark-Head & Face Medicine 2007, 3:40 http://www.head-face-med.com/content/3/1/40
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ers that must be compared in order to discern their differ-
ential activity.
RP59, is a protein expressed in bone marrow cells and
osteoblasts with implication in osteoblast recruitment,
and it has also been detected in primitive mesenchymal
cells, erythroid cells, and megacaryocytes [41,17]. RP59 is
also a marker of differentiating odontoblast progenitors
[19]. However, RP59 has also been identified in the form-
ing enamel and ameloblasts [18], and therefore the specif-
icity of this marker is questionable. Osteopontin (OPN) is
a matricellular molecule and a structural protein promi-
nently present in mineralized tissues [34]. As a member of
the SIBLING family [10] it is phosphorylated to different
extents in the ECM in different tissues. In vitro, OPN is a
mineralization inhibitor [4,25]. It also functions as a
response to stress and a mediator of inflammation [11,8].
Thus OPN is not an exclusive marker of the osteoblastic
phenotype. Similarly, for years, DSP a peptide derived
from the SIBLING protein DSPP by specific proteolytic
cleavage was believed to be odontoblast-specific. How-
ever, its presence has also been recognized in osteoblasts
in a 1/400 ratio [27] and in a few non-mineralizing tissues
such as kidney, salivary glands and tumor cells [25].
Although the specificity of each marker remains a matter
of discussion, at least the three of them altogether allow
characterizing the cascade of early events if they are related
to mineralization, odontogenesis or osteogenesis.
Effects of bead implantation (control pulps)
Labeling for PCNA was increased between 1 and 7 days,
indicating a steady cell growth during the repair process
(Figs 1a, b). In contrast, the RP59 (presumed osteoblast/
odontoblast differentiation marker) labeling level was
weak on day 1 and was not increased at 3 and 7 days (Figs
1c, d). OPN, the marker for both cell inflammation and
osteoblastic character was weak at day 1, moderately
stronger at day 3 but not further enhanced by day 7 (Figs
1e, f). DSP labeling was negative at each time (Figs 1g, h).
Effects of implantation of beads soaked with A+4
No PCNA labeling was detectable at day 1. At day 3, labe-
ling was strong, but had decreased sharply at day 7 (Figs
2a, b). Similarly, RP59 labeling was increased between
days 1 and 3 but had declined at day 7 (Fig 2c). For the
short periods of time studied here, OPN labeling was
increasing between days 1–3, and reinforced at day 7 (Figs
2d,e), whereas DSP labeling was null all time periods (Fig
2f).
Implantation of beads alone Figure 1
Implantation of beads alone. PCNA staining at day-3 and -7 (1a, b). RP59 at day -1 and -3 (1c, d). Immunostaining for osteopon-
tin (OPN) at day -1 and -3 (1e, f), and for DSP for the same periods of time (1g, h).Head & Face Medicine 2007, 3:40 http://www.head-face-med.com/content/3/1/40
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Effects of implantation of beads soaked with A-4
PCNA labeling was weak at day 1, and enhanced at days 3
and 7 (Figs 3a–c). The same occurred for RP59 labeling
(Figs 3d–f). OPN, negative at day 1, became positive at
days 3 and 7 (Figs 4a, b). DSP labeling was undetectable
at days 1–3, but had begun to display weak labeling of a
few cells at day 7 (Figs 4c, d).
Figures 5A–C reflect the difference in behavior of the four
markers upon exposure of the pulp cells to the beads +/-
amelogenin peptides. These data relative to PCNA indi-
cate that while implantation of the beads alone does not
impair the steady growth of the cells in the vicinity of the
beads, the addition of A+4 or A-4 initially stimulates the
cell growth rate, albeit in a differential fashion, with the
A+4 effect dropping sharply after 7 days, while the A-4
effect is more long lasting (Fig 5A). Similar differential
effects are seen for the osteogenic (RP59) and bone phe-
notypic (OPN) markers (Figs 5B, C). The effect of A+4 is
markedly different from A-4 with regard to length of time
for the development of the OPN response. The DSP
appearance resulting from both A+4 and A-4 is not appar-
ent until day 7, and then only to a limited extent in small
groups of cells.
Discussion
Potential biological effects of agarose beads
The present results shed light on the short-term effects of
agarose beads alone or beads soaked with A+4 or A-4
implanted in the exposed pulp. Each of the two bioactive
molecules has its own specificity. Shortly after implanta-
tion of bioactive molecules in the dental pulp, it appears
that some pulp cells differentiate along the osteoblast-like
progenitor phenotype.
As agarose is a linear sulphated galactan, implantation of
beads alone may have some effects on pulp repair. Antivi-
ral and anticoagulant properties have been already
reported [5,20]. They may interfere with the initial steps
of pulp healing. A slight inflammatory reaction was
detected, and pulp cell proliferation was initiated at day 3
and enhanced at day 7. However, none of the other mark-
ers provide any evidence for progenitor differentiation
into osteoblast-like cells. Rodents have a tendency to self-
repair and a limited spontaneous healing was observed
after the surgery as reported previously [7]. However,
healing after the surgery and bead implantation took
longer periods of time, and was only partial even after 30
days, compared with the effects of two amelogenin mole-
cules for the same period of time [33].
Implantation of agarose beads soaked in A+4 Figure 2
Implantation of agarose beads soaked in A+4. PCNA staining at day 3 and 7 (2a, b), RP59 at day 3 (2c), OPN at days 3 and 7 
(2d, e). No staining is seen for DSP (2f).Head & Face Medicine 2007, 3:40 http://www.head-face-med.com/content/3/1/40
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Short-term effects of A +/- 4
How cells are committed still needs to be clarified, and
probably an in vitro approach is more appropriate to fur-
ther elucidate the mechanisms involved. Altogether, our
data suggest that immediately after implantation of A +/-
4, the reparative process initiated by the two spliced amel-
ogenins implicates three consecutive steps for the periods
of time studied here.
Firstly, the committed cells proliferate, as shown by PCNA
staining. These cells are located not only near the exposure
site, but also in the central cusp at 3 days and 7 days. They
migrate and after 7 days and at 15 days, labeled cells are
seen surrounding the carrier beads. They are never located
at the immediate surface, but they form the second row of
the ring of cells located around the beads [33]. Dormant
progenitors that are committed divide until the required
number of cells is obtained to produce the ECM mole-
cules necessary to form a reparative dentinal bridge or dif-
fuse mineralization.
Secondly, the cascade of events pushes some cells toward
an early differentiation of RP59-positive progenitor cells.
As the RP59-positive cells are less numerous than the
PCNA-positive cells, this suggests that all the cells are not
transformed, but that some are selected according to
unknown criteria.
As a third step, as shown by OPN immunostaining, some
of the RP59-positive cells undergo the final differentiation
toward the osteoblast-like lineage, despite implantation
into the dental pulp which would in theory implicate
their differentiation to odontoblast-like progenitors. The
kinetics of the reaction supports the interpretation that in
this case OPN, after the immediate inflammatory
response from days 1 to 3, ceases to play its role as an
inflammatory molecule, but rather characterizes osteob-
last progenitors. Labeling for DSP is a late-occurring event,
detect only after 7 days within a very few cells stimulated
by A-4 alone. Either some osteoblast-like cells gradually
acquire the odontoblast phenotype and display late termi-
nal differentiation, or a second group of cells are recruited
at a slower rate and they show a different phenotype. At
the moment, in vitro data on clones of progenitors suggest
that the cells are osteo/odontoblast progenitors [26], but
when amelogenins are added to the culture medium,
clones express DSP after 48 h both for A+4 and A-4, results
divergent from the present in vivo data [19].
We have previously shown that 30 days after A+4 implan-
tation, the formation of a reparative dentine bridge is
observed, while A-4 stimulates the formation of a diffuse
pulp mineralization occurring both in the crown and root
parts of the pulp [33]. Therefore, the 14 amino acids that
constitute the transcripts of exon 4 and make the differ-
Implantation of A-4 Figure 3
Implantation of A-4. PCNA at days 1, 3 and 7 (3a-c). RP59 staining at days 1, 3, and 7 (3d-f).Head & Face Medicine 2007, 3:40 http://www.head-face-med.com/content/3/1/40
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e nce between the M73, A+4 and M59, A-4, seem to consti-
tute a specific domain regulating the speed and nature of
the differing responses. In in vitro tissue culture experi-
ments that examined the effects of the two bioactive mol-
ecules we saw that within 24 to 48 hours of their addition
to the cells, upregulation of factors such as SOX9 and
Runx2 was evident [40]. Although in vivo responses do
take considerably longer times, the proteomics approach
to examination of the early gene responses on a more glo-
bal level will be required to understand the mode of
action of the amelogenin peptides in detail.
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